MSD Vietnam proactive in combating COVID-19

MSD Vietnam joined member companies of the EuroCham Pharma Group to donate $100,000 to Vietnam's fight against COVID-19

The efforts to achieve the goal has led the company to important local public and private partnerships, helping to address some of the most pressing healthcare needs in Vietnam, including antimicrobial stewardship, maternal healthcare (MSD for Mothers), access to specialty care for complex, chronic conditions in underserved communities, and supporting the roll-out of HPV vaccination to achieve the United Nations Sustainable Development Goals.

As the world faces the COVID-19 pandemic, and the search for vaccines and therapeutics are underway, MSD has proven proactive in supporting Vietnam’s efforts to assist those who are directly involved in managing the COVID-19 pandemic.

In April, along with the American Chamber of Commerce Vietnam (AmCham Vietnam), MSD joined member companies to donate 250,000 face masks to frontline health workers in Ho Chi Minh City, assisting those who are directly involved in managing COVID-19 at the city’s hospitals and quarantine facilities.

In May, along with the PharmaGroup (consisting of all research-based pharmaceutical companies from Japan, Europe, and the US under the European Chamber of Commerce in Vietnam) MSD joined member companies to donate an equivalent of $100,000 to the Vietnam Fatherland Front national campaign for the prevention and treatment of COVID-19.

Donating real-time PCR machine to Ho Chi Minh City for COVID-19 testing

MSD, together with other members of AmCham Vietnam, recently delivered a real-time Polymerase Chain Reaction (PCR) machine to the Ho Chi Minh City Centre for Disease Control and Prevention for COVID-19 testing.

“As a company dedicated to saving and improving lives, MSD is engaged in multiple efforts to do our part in addressing the COVID-19 pandemic,” said Koen C. Kruytbosch, managing director, MSD Vietnam.

“Our continued donation to the national campaign on the prevention and treatment of COVID-19 shows both our commitments to the government in its fight against the new coronavirus and to making a difference for the people in Vietnam and their long-term health and welfare. We are committed to and will continue to work hard on the aspiration to be the most admired and trusted healthcare partner in Vietnam,” he noted.

As part of the company’s response to the COVID-19 pandemic, MSD is pursuing multiple efforts, including research across basic science, treatment, and prevention. Building on MSD experience with antivirals and vaccines, MSD is accelerating two COVID-19 vaccine development efforts and a novel antiviral candidate.

MSD is a global leader in infectious diseases and vaccines, with a decades-long history of researching, developing, manufacturing and distributing vaccines for children, adolescents, and adults.

In response to the COVID-19 pandemic, MSD is focused on protecting the safety of its employees and their families, ensuring that its supply of medicines and vaccines reaches patients and customers, contributing its scientific expertise to the development of antiviral and vaccine approaches and supporting healthcare providers and communities.